Moxifloxacin labels and packages

Revision as of 08:49, 9 January 2014 by Abdurahman Khalil (talk | contribs) (Created page with "__NOTOC__ {{Moxifloxacin}} {{CMG}};{{AE}}{{AK}} Rx Only ©2012 Bayer HealthCare Pharmaceuticals Inc. 83680831, R.4 '''Avelox® I.V. (moxifloxacinHCl in NaCl injection) ...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Moxifloxacin
AVELOX® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]


Rx Only

©2012 Bayer HealthCare Pharmaceuticals Inc.

83680831, R.4

Avelox® I.V.

(moxifloxacinHCl in NaCl injection)

400 mg*/250 mL 0.8% Saline (1.6 mg/mL)

INFUSE OVER A PERIOD OF 60 MINUTES

NDC 0085-1737-01 08917631

Avelox Five Tablet Carton 08917542 NDC 0085-1733-03

Aveloxmoxifloxacin HCI Tablets

FIVE TABLETS

ABC PACK

AVELOX BRONCHITIS COURSE

For Acute Bacterial Exacerbation of Chronic Bronchitis

Attention Pharmacist: Dispense the accompanying Medication Guide to each patient.

One Tablet, Once Daily for Just 5 Days

Rx Only

This pack is intended for the teatment of brochitis. Other conditions may require a longer duration of therapy.

References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21277slr018,21085slr023_avelox_lbl.pdf